Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Emphysema Companies

Emphysema companies focus on providing medical solutions for individuals with emphysema, a chronic lung condition characterized by the destruction of lung tissue. These companies contribute to pulmonology by offering medications, inhalers, and therapies to manage and improve respiratory function in individuals with emphysema.

Emphysema Key Companies Latest Emphysema Companies Update

AstraZeneca (Symbicort®) Partnered with healthcare providers to launch educational programs highlighting the benefits of long-acting bronchodilator/inhaled corticosteroid combination therapies for managing chronic symptoms and improving quality of life in emphysema patients.

GlaxoSmithKline (Advair®) Focused on research and development of longer-acting versions of existing medications to potentially increase treatment adherence and improve outcomes for emphysema patients.

Respironics (Philips Healthcare) Announced the expansion of their Trilogy® series of portable ventilators specifically designed for home-based pulmonary rehabilitation programs, improving accessibility for emphysema patients.

Lung Foundation of America Received grants to pilot innovative virtual and hybrid pulmonary rehabilitation programs, aimed at increasing access and engagement for patients in remote areas or facing mobility limitations.

Medtronic (Zephyr® Endobronchial Valve) Presented positive results from clinical trials on the effectiveness of their valve placement system in improving lung function and exercise capacity in emphysema patients.

Spiration Therapeutics (AeriSeal® System) Focused on exploring potential applications of their lung volume reduction technology for treating early-stage emphysema and preventing disease progression.List of Emphysema Key Companies in the Market

Intrexon Corporation

Pulmonx Inc.

Halozyme Therapeutics, Inc.

Mariposa Health Limited

PneumRx

Uptake Medical Corporation

Icure Pharmaceuticals, Inc.

Pfizer, Inc.

BTG International’s

Olympus Corporation

Kamada Limited

Emphasys Medical, Inc.

Emphysema Market Highlights:

Emphysema Market Size

Emphysema Market Trends

Emphysema Market Analysis

Emphysema Market Share

Emphysema Market Highlights:

Emphysema Market Trends

Emphysema Market Analysis

Emphysema Market Share

Emphysema Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.